Current management of vulvar cancer

Hematology/Oncology Clinics of North America

Volumn 26, Issue 1, 2012, Pages 45-62

  Fuh, Katherine C ^a   Berek, Jonathan S ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD CANCER INSTITUTE   (United States)

Author keywords

Inguinofemoral lymphadenectomy; Modified radical vulvectomy; Radical local excision; Sentinel lymph node biopsy; Vulvar cancer

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADENOCARCINOMA; ADJUVANT CHEMORADIOTHERAPY; BASAL CELL CARCINOMA; CANCER STAGING; CONTINUOUS INFUSION; HUMAN; INGUINAL LYMPH NODE; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MELANOMA; PATHOLOGY; PELVIS EXENTERATION; PRIORITY JOURNAL; REVIEW; SARCOMA; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA; VULVA CANCER; VULVECTOMY;

FEMALE; GROIN; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY; VULVAR NEOPLASMS;

EID: 84855879414     PISSN: 08898588     EISSN: 15581977     Source Type: Journal    
DOI: 10.1016/j.hoc.2011.10.006     Document Type: Review

References (59)

1. Jemal A., Bray F., Center M.M., et al. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90.
2. Way S. Carcinoma of the vulva. Am J Obstet Gynecol 1960, 79:692-697.
3. Monaghan J.M. Vulvar carcinoma: the case for individualization of treatment. Baillieres Clin Obstet Gynaecol 1987, 1(2):263-276.
4. Hoffman J.S., Kumar N.B., Morley G.W. Prognostic significance of groin lymph node metastases in squamous carcinoma of the vulva. Obstet Gynecol 1985, 66(3):402-405.
5. Homesley H.D., Bundy B.N., Sedlis A., et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol 1991, 164(4):997-1003. [discussion: 1003-4].
6. Hildesheim A., Han C.L., Brinton L.A., et al. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study. Obstet Gynecol 1997, 90(5):748-754.
7. Iwasawa A., Nieminen P., Lehtinen M., et al. Human papillomavirus in squamous cell carcinoma of the vulva by polymerase chain reaction. Obstet Gynecol 1997, 89(1):81-84.
8. Sugiyama V.E., Chan J.K., Shin J.Y., et al. Vulvar melanoma: a multivariable analysis of 644 patients. Obstet Gynecol 2007, 110(2 Pt 1):296-301.
9. de Giorgi V., Salvini C., Massi D., et al. Vulvar basal cell carcinoma: retrospective study and review of literature. Gynecol Oncol 2005, 97(1):192-194.
10. Benedet J.L., Miller D.M., Ehlen T.G., et al. Basal cell carcinoma of the vulva: clinical features and treatment results in 28 patients. Obstet Gynecol 1997, 90(5):765-768.
11. Felix J.C., Cote R.J., Kramer E.E., et al. Carcinomas of Bartholin's gland. Histogenesis and the etiological role of human papillomavirus. Am J Pathol 1993, 142(3):925-933.
12. Copeland L.J., Sneige N., Gershenson D.M., et al. Bartholin gland carcinoma. Obstet Gynecol 1986, 67(6):794-801.
13. Parker L.P., Parker J.R., Bodurka-Bevers D., et al. Paget's disease of the vulva: pathology, pattern of involvement, and prognosis. Gynecol Oncol 2000, 77(1):183-189.
14. Fanning J., Lambert H.C., Hale T.M., et al. Paget's disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence after surgical excision. Am J Obstet Gynecol 1999, 180(1 Pt 1):24-27.
15. Taussig F.J. Cancer of the vulva: an analysis of 155 cases. Am J Obstet Gynecol 1940, 79:692-699.
16. Hacker N.F., Berek J.S., Lagasse L.D., et al. Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet Gynecol 1984, 63(2):155-162.
17. Hacker N.F., Leuchter R.S., Berek J.S., et al. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol 1981, 58(5):574-579.
18. Rouzier R., Haddad B., Atallah D., et al. Surgery for vulvar cancer. Clin Obstet Gynecol 2005, 48(4):869-878.
19. DeSimone C.P., Van Ness J.S., Cooper A.L., et al. The treatment of lateral T1 and T2 squamous cell carcinomas of the vulva confined to the labium majus or minus. Gynecol Oncol 2007, 104(2):390-395.
20. Tantipalakorn C., Robertson G., Marsden D.E., et al. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer. Obstet Gynecol 2009, 113(4):895-901.
21. Farias-Eisner R., Cirisano F.D., Grouse D., et al. Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) disease. Gynecol Oncol 1994, 53(1):55-58.
22. Chan J.K., Sugiyama V., Pham H., et al. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol 2007, 104(3):636-641.
23. Heaps J.M., Fu Y.S., Montz F.J., et al. Surgical-pathologic variables predictive oflocal recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 1990, 38(3):309-314.
24. Wilkinson E.J., Rico M.J., Pierson K.K. Microinvasive carcinoma of the vulva. Int J Gynecol Pathol 1982, 1(1):29-39.
25. Magrina J.F., Webb M.J., Gaffey T.A., et al. Stage I squamous cell cancer of the vulva. Am J Obstet Gynecol 1979, 134(4):453-459.
26. Sedlis A., Homesley H., Bundy B.N., et al. Positive groin lymph nodes in superficial squamous cell vulvar cancer. A Gynecologic Oncology Group Study. Am J Obstet Gynecol 1987, 156(5):1159-1164.
27. Hacker N.F., Van der Velden J. Conservative management of early vulvar cancer. Cancer 1993, 71(Suppl 4):1673-1677.
28. Atamdede F., Hoogerland D. Regional lymph node recurrence following local excision for microinvasive vulvar carcinoma. Gynecol Oncol 1989, 34(1):125-128.
29. Van Der Velden J., Kooyman C.D., Van Lindert A.C., et al. Astage Ia vulvar carcinoma with an inguinal lymph node recurrence after local excision. A case report and literature review. Int J Gynecol Cancer 1992, 2(3):157-159.
30. Vernooij F., Sie-Go D.M., Heintz A.P. Lymph node recurrence following stage IA vulvar carcinoma: two cases and a short overview of literature. Int J Gynecol Cancer 2007, 17(2):517-520.
31. Stehman F.B., Bundy B.N., Dvoretsky P.M., et al. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol 1992, 79(4):490-497.
32. Iversen T., Aas M. Lymph drainage from the vulva. Gynecol Oncol 1983, 16(2):179-189.
33. Homesley H.D., Bundy B.N., Sedlis A., et al. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study). Gynecol Oncol 1993, 49(3):279-283.
34. Micheletti L., Levi A.C., Bogliatto F., et al. Rationale and definition of the lateral extension of the inguinal lymphadenectomy for vulvar cancer derived from an embryological and anatomical study. JSurg Oncol 2002, 81(1):19-24.
35. Dardarian T.S., Gray H.J., Morgan M.A., et al. Saphenous vein sparing during inguinal lymphadenectomy to reduce morbidity in patients with vulvar carcinoma. Gynecol Oncol 2006, 101(1):140-142.
36. Zhang X., Sheng X., Niu J., et al. Sparing of saphenous vein during inguinal lymphadenectomy for vulval malignancies. Gynecol Oncol 2007, 105(3):722-726.
37. Barton D.P., Berman C., Cavanagh D., et al. Lymphoscintigraphy in vulvar cancer: a pilot study. Gynecol Oncol 1992, 46(3):341-344.
38. Levenback C., Coleman R.L., Burke T.W., et al. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol 2001, 83(2):276-281.
39. Van der Zee A.G., Oonk M.H., De Hullu J.A., et al. Sentinel node dissection is safe inthe treatment of early-stage vulvar cancer. JClin Oncol 2008, 26(6):884-889.
40. Dhar K.K., Woolas R.P. Lymphatic mapping and sentinel node biopsy in early vulvar cancer. BJOG 2005, 112(6):696-702.
41. de Hullu J.A., Hollema H., Piers D.A., et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. JClin Oncol 2000, 18(15):2811-2816.
42. Ansink A., van der Velden J. Surgical interventions for early squamous cell carcinoma of the vulva. Cochrane Database Syst Rev 2000, 2. CD002036.
43. Moore R.G., DePasquale S.E., Steinhoff M.M., et al. Sentinel node identification and the ability to detect metastatic tumor to inguinal lymph nodes in squamous cell cancer of the vulva. Gynecol Oncol 2003, 89(3):475-479.
44. De Cicco C., Sideri M., Bartolomei M., et al. Sentinel node biopsy in early vulvar cancer. Br J Cancer 2000, 82(2):295-299.
45. Hyde S.E., Valmadre S., Hacker N.F., et al. Squamous cell carcinoma of the vulva with bulky positive groin nodes-nodal debulking versus full groin dissection prior to radiation therapy. Int J Gynecol Cancer 2007, 17(1):154-158.
46. Thomas G., Dembo A., DePetrillo A., et al. Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol Oncol 1989, 34(3):263-267.
47. Gerszten K., Selvaraj R.N., Kelley J., et al. Preoperative chemoradiation for locally advanced carcinoma of the vulva. Gynecol Oncol 2005, 99(3):640-644.
48. Koh W.J., Wallace H.J., Greer B.E., et al. Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar cancer. Int J Radiat Oncol Biol Phys 1993, 26(5):809-816.
49. Gaffney D.K., Du Bois A., Narayan K., et al. Patterns of care for radiotherapy invulvar cancer: a Gynecologic Cancer Intergroup study. Int J Gynecol Cancer 2009, 19(1):163-167.
50. van Doorn H.C., Ansink A., Verhaar-Langereis M., et al. Neoadjuvant chemoradiation for advanced primary vulvar cancer. Cochrane Database Syst Rev 2006, 3. CD003752.
51. Barnhill D.R., Hoskins W.J., Metz P. Use of the rhomboid flap after partial vulvectomy. Obstet Gynecol 1983, 62(4):444-447.
52. Ballon S.C., Donaldson R.C., Roberts J.A., et al. Reconstruction of the vulva using a myocutaneous graft. Gynecol Oncol 1979, 7(2):123-127.
53. Chafe W., Fowler W.C., Walton L.A., et al. Radical vulvectomy with use of tensor fascia lata myocutaneous flap. Am J Obstet Gynecol 1983, 145(2):207-213.
54. Deppe G., Bruckner H.W., Cohen C.J. Adriamycin treatment of advanced vulvar carcinoma. Obstet Gynecol 1977, 50(Suppl 1):13s-14s.
55. Gadducci A., Cionini L., Romanini A., et al. Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. Crit Rev Oncol Hematol 2006, 60(3):227-241.
56. Witteveen P.O., van der Velden J., Vergote I., et al. Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group). Ann Oncol 2009, 20(9):1511-1516.
57. Trope C., Johnsson J.E., Larsson G., et al. Bleomycin alone or combined with mitomycin C in treatment of advanced or recurrent squamous cell carcinoma of the vulva. Cancer Treat Rep 1980, 64(4-5):639-642.
58. Muss H.B., Bundy B.N., Christopherson W.A. Mitoxantrone in the treatment ofadvanced vulvar and vaginal carcinoma. A Gynecologic Oncology Group study. Am J Clin Oncol 1989, 12(2):142-144.
59. Cormio G., Loizzi V., Gissi F., et al. Cisplatin and vinorelbine chemotherapy in recurrent vulvar carcinoma. Oncology 2009, 77(5):281-284.